Swissmedic is expected to decide on the approval of the first new drug for Alzheimer’s disease in two decades. The decision ...

New chief Pamela Rendi-Wagner says European Centre for Disease Prevention and Control (ECDC) should do more to combat ...

European Union suspends Pfizer's Oxbryta for sickle cell disease due to safety concerns, urging doctors to stop use ...

HANSIZHUANG ® (serplulimab) was the first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC – ...

The Belgian medicines agency, an important stakeholder in the revision of the European pharmaceutical legislation, is ...

U.S. stocks reacted positively following the Federal Open Market Committee's announcement in mid-September that it would lower interest rates by 50 basis points, wider than many analysts had ...

Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an update of Novo Nordisk A/S’ (NYSE ...

Committee for Human Medicinal Products (CHMP) recommended approval of five novel medicines at its September meeting ...

Greater collaboration between industry, government, policymakers and the NHS will be critical for treatment options in the UK ...

EMA’s human medicines committee elects Bruno Sepodes as new chair: Amsterdam, The Netherlands Friday, September 20, 2024, ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

Merck & Co. said a European Medicines Agency panel recommended expanded approval of the drugmaker's blockbuster cancer treatment Keytruda in two types of gynecologic cancers.